InvestorsHub Logo

hope4patients

08/21/22 7:13 AM

#506873 RE: Guzzi62 #506872

I agree completely.

LessIsMore

08/21/22 7:46 AM

#506874 RE: Guzzi62 #506872

No doubt that Dr. Ashkan is highly respected but linking to a Smithonstocks article makes the statement lose all credibility. Outside of NWBO nobody has ever heard of Smith.

In addition Dr. Ashkan was a key investigator in the trial thus he is not truly independent, the possibility of confirmation bias must be considered.

When will we see an independent peer-reviewed analysis of the data in hand? Many are waiting on this.

dr_lowenstein

08/26/22 3:46 PM

#508402 RE: Guzzi62 #506872

of course he is favorable he is paid to be favorable

biosectinvestor

08/29/22 5:35 PM

#509143 RE: Guzzi62 #506872

Agreed.